Tsumura & Co. (4540.T)
JPY 4759.0
(-0.69%)
JPY 4759.0
(-0.69%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 20.01 Billion JPY | -4.29% |
| 2022 | 20.91 Billion JPY | -6.52% |
| 2021 | 22.37 Billion JPY | 15.45% |
| 2020 | 19.38 Billion JPY | 2.68% |
| 2019 | 18.87 Billion JPY | 1.92% |
| 2018 | 18.52 Billion JPY | 8.62% |
| 2017 | 17.05 Billion JPY | 6.68% |
| 2016 | 15.98 Billion JPY | -19.38% |
| 2015 | 19.82 Billion JPY | 1.72% |
| 2014 | 19.49 Billion JPY | -13.22% |
| 2013 | 22.46 Billion JPY | -2.87% |
| 2012 | 23.12 Billion JPY | 8.9% |
| 2011 | 21.23 Billion JPY | -1.49% |
| 2010 | 21.55 Billion JPY | 13.81% |
| 2009 | 18.94 Billion JPY | 14.91% |
| 2008 | 16.48 Billion JPY | 4.18% |
| 2007 | 15.82 Billion JPY | 2.02% |
| 2006 | 15.5 Billion JPY | -5.84% |
| 2005 | 16.46 Billion JPY | 37.65% |
| 2004 | 11.96 Billion JPY | 6.6% |
| 2003 | 11.22 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 10.57 Billion JPY | 1109.95% |
| 2023 Q1 | 4.68 Billion JPY | 46.7% |
| 2023 Q4 | 874 Million JPY | -90.21% |
| 2023 FY | 20.01 Billion JPY | -4.29% |
| 2023 Q3 | 8.93 Billion JPY | 61.61% |
| 2023 Q2 | 5.52 Billion JPY | 18.0% |
| 2022 Q3 | 6.04 Billion JPY | 13.56% |
| 2022 FY | 20.91 Billion JPY | -6.52% |
| 2022 Q1 | 6.35 Billion JPY | 79.11% |
| 2022 Q2 | 5.32 Billion JPY | -16.2% |
| 2022 Q4 | 3.19 Billion JPY | -47.19% |
| 2021 Q4 | 3.54 Billion JPY | -50.36% |
| 2021 FY | 22.37 Billion JPY | 15.45% |
| 2021 Q1 | 6.15 Billion JPY | 237.65% |
| 2021 Q2 | 5.53 Billion JPY | -10.08% |
| 2021 Q3 | 7.14 Billion JPY | 29.16% |
| 2020 Q4 | 1.82 Billion JPY | -71.69% |
| 2020 Q1 | 5.73 Billion JPY | 110.35% |
| 2020 Q2 | 5.39 Billion JPY | -5.93% |
| 2020 Q3 | 6.43 Billion JPY | 19.36% |
| 2020 FY | 19.38 Billion JPY | 2.68% |
| 2019 Q3 | 6.37 Billion JPY | 40.23% |
| 2019 FY | 18.87 Billion JPY | 1.92% |
| 2019 Q1 | 5.23 Billion JPY | 61.42% |
| 2019 Q2 | 4.54 Billion JPY | -13.08% |
| 2019 Q4 | 2.72 Billion JPY | -57.25% |
| 2018 Q2 | 4.39 Billion JPY | -3.69% |
| 2018 Q3 | 6.33 Billion JPY | 44.16% |
| 2018 Q4 | 3.24 Billion JPY | -48.82% |
| 2018 Q1 | 4.55 Billion JPY | 138.07% |
| 2018 FY | 18.52 Billion JPY | 8.62% |
| 2017 Q3 | 6.15 Billion JPY | 35.34% |
| 2017 Q2 | 4.54 Billion JPY | 2.32% |
| 2017 Q4 | 1.91 Billion JPY | -68.86% |
| 2017 Q1 | 4.44 Billion JPY | 122.27% |
| 2017 FY | 17.05 Billion JPY | 6.68% |
| 2016 FY | 15.98 Billion JPY | -19.38% |
| 2016 Q2 | 3.37 Billion JPY | -24.73% |
| 2016 Q3 | 6.11 Billion JPY | 81.03% |
| 2016 Q4 | 1.99 Billion JPY | -67.34% |
| 2016 Q1 | 4.48 Billion JPY | 18.54% |
| 2015 FY | 19.82 Billion JPY | 1.72% |
| 2015 Q4 | 3.78 Billion JPY | -38.76% |
| 2015 Q2 | 5.06 Billion JPY | 5.87% |
| 2015 Q3 | 6.18 Billion JPY | 22.02% |
| 2015 Q1 | 4.78 Billion JPY | 28.54% |
| 2014 Q4 | 3.72 Billion JPY | -48.15% |
| 2014 Q1 | 4.51 Billion JPY | -11.82% |
| 2014 Q2 | 4.07 Billion JPY | -9.81% |
| 2014 FY | 19.49 Billion JPY | -13.22% |
| 2014 Q3 | 7.18 Billion JPY | 76.42% |
| 2013 Q4 | 5.11 Billion JPY | -26.62% |
| 2013 FY | 22.46 Billion JPY | -2.87% |
| 2013 Q1 | 5.37 Billion JPY | 20.16% |
| 2013 Q2 | 4.99 Billion JPY | -6.96% |
| 2013 Q3 | 6.97 Billion JPY | 39.63% |
| 2012 Q1 | 6.04 Billion JPY | 55.7% |
| 2012 Q4 | 4.46 Billion JPY | -41.36% |
| 2012 Q2 | 4.98 Billion JPY | -17.48% |
| 2012 Q3 | 7.62 Billion JPY | 52.76% |
| 2012 FY | 23.12 Billion JPY | 8.9% |
| 2011 Q4 | 3.88 Billion JPY | -48.36% |
| 2011 FY | 21.23 Billion JPY | -1.49% |
| 2011 Q1 | 6.02 Billion JPY | 15.43% |
| 2011 Q3 | 7.52 Billion JPY | 97.38% |
| 2011 Q2 | 3.81 Billion JPY | -36.72% |
| 2010 Q1 | 5.19 Billion JPY | 58.83% |
| 2010 Q3 | 6.52 Billion JPY | 41.3% |
| 2010 Q4 | 5.21 Billion JPY | -20.1% |
| 2010 FY | 21.55 Billion JPY | 13.81% |
| 2010 Q2 | 4.62 Billion JPY | -11.02% |
| 2009 FY | 18.94 Billion JPY | 14.91% |
| 2009 Q4 | 3.26 Billion JPY | -51.27% |
| 2009 Q3 | 6.7 Billion JPY | 51.66% |
| 2009 Q2 | 4.42 Billion JPY | -2.6% |
| 2009 Q1 | 4.54 Billion JPY | 37.52% |
| 2008 Q4 | 3.3 Billion JPY | -40.36% |
| 2008 Q2 | 3.63 Billion JPY | 0.0% |
| 2008 FY | 16.48 Billion JPY | 4.18% |
| 2008 Q3 | 5.53 Billion JPY | 52.45% |
| 2007 FY | 15.82 Billion JPY | 2.02% |
| 2006 FY | 15.5 Billion JPY | -5.84% |
| 2005 FY | 16.46 Billion JPY | 37.65% |
| 2004 FY | 11.96 Billion JPY | 6.6% |
| 2003 FY | 11.22 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 5.11 Billion JPY | -291.512% |
| Takeda Pharmaceutical Company Limited | 214.07 Billion JPY | 90.649% |
| Sumitomo Pharma Co., Ltd. | -354.19 Billion JPY | 105.652% |
| Shionogi & Co., Ltd. | 171.46 Billion JPY | 88.325% |
| Wakamoto Pharmaceutical Co.,Ltd. | -195.51 Million JPY | 10338.81% |
| Nippon Shinyaku Co., Ltd. | 31.38 Billion JPY | 36.22% |
| Kaken Pharmaceutical Co., Ltd. | 9.51 Billion JPY | -110.428% |
| Eisai Co., Ltd. | 53.4 Billion JPY | 62.519% |
| Morishita Jintan Co., Ltd. | 716 Million JPY | -2695.81% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.16 Billion JPY | -52.032% |
| Mochida Pharmaceutical Co., Ltd. | 5.8 Billion JPY | -244.96% |
| Fuso Pharmaceutical Industries,Ltd. | 1.96 Billion JPY | -919.246% |
| Nippon Chemiphar Co., Ltd. | -494 Million JPY | 4152.227% |
| Kissei Pharmaceutical Co., Ltd. | 4.01 Billion JPY | -398.332% |
| Torii Pharmaceutical Co., Ltd. | 5.03 Billion JPY | -297.498% |
| Towa Pharmaceutical Co., Ltd. | 17.64 Billion JPY | -13.429% |
| Fuji Pharma Co., Ltd. | 3.85 Billion JPY | -418.87% |
| Zeria Pharmaceutical Co., Ltd. | 9.71 Billion JPY | -106.018% |
| KYORIN Holdings, Inc. | 6.01 Billion JPY | -232.912% |
| Taiko Pharmaceutical Co.,Ltd. | -3.07 Billion JPY | 750.146% |
| Daito Pharmaceutical Co.,Ltd. | 3.89 Billion JPY | -414.073% |
| SymBio Pharmaceuticals Limited | -811.66 Million JPY | 2566.279% |
| MedRx Co., Ltd | -933 Million JPY | 2245.552% |
| Mizuho Medy Co.,Ltd. | 5.15 Billion JPY | -288.549% |
| Solasia Pharma K.K. | -1.13 Billion JPY | 1857.507% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 944.641% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 6.5 Billion JPY | -207.969% |
| Sawai Group Holdings Co., Ltd. | 18.88 Billion JPY | -5.994% |
| Cyfuse Biomedical K.K. | -697.43 Million JPY | 2970.223% |
| Toho Holdings Co., Ltd. | 19.33 Billion JPY | -3.554% |
| Koa Shoji Holdings Co.,Ltd. | 4.38 Billion JPY | -356.791% |